✦ LIBER ✦

Cytotoxic T lymphocyte recognition of non-Hodgkin’s B cell lymphomas

✍ Scribed by Alan M. Krensky

Book ID: 112936779
Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 611 KB
Volume: 15
Category: Article
ISSN: 0257-277X
DOI: 10.1007/bf02918499

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T-lymphocyte subpopulations in B-cell-de

T-lymphocyte subpopulations in B-cell-derived non-hodgkin's lymphomas and hodgkin's disease

✍ Daniel M. Knowles II; James P. Halper; Frederick A. Jakobiec 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 914 KB

Cytotoxic T-cell non-Hodgkin's lymphoma

Cytotoxic T-cell non-Hodgkin's lymphoma of the thyroid gland

✍ Akio Okamoto; Kyoko Namura; Hitoji Uchiyama; Yoshihiro Kajita; Tohru Inaba; Shig 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

T OR B CELL ORIGIN OF SOME NON-HODGKIN'S

T OR B CELL ORIGIN OF SOME NON-HODGKIN'S LYMPHOMAS

✍ Peter, ChristopherR.; Mackenzie, MalcolmR.; Glassy, FrankJ. 📂 Article 📅 1974 🏛 The Lancet 🌐 English ⚖ 560 KB

T-cell rich B-cell non-Hodgkin's lymphom

T-cell rich B-cell non-Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease

✍ H.F. Stringfellow; S. Wells 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

T-cell rich B-cell non-Hodgkin's lymphom

T-cell rich B-cell non-Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease

✍ D.de Jong; J.van Gorp; D. Sie-Go; P.van Heerde 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

AGGRESSIVE NON-HODGKIN'S LYMPHOMA: T-CEL

AGGRESSIVE NON-HODGKIN'S LYMPHOMA: T-CELL VERSUS B-CELL

✍ RAYMOND LIANG; DAVID TODD; FAITH C. S. HO 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

This study aimed to define the clinical characteristics, treatment outcome and independent prognostic factors of 144 patients with T-and 357 B-cell non-Hodgkin's lymphomas. Entities with well-defined immunophenotype and clinical characteristics were excluded. Patients with T-cell tumours were younge